US Pharma MarketingBayer’s heart failure drug bound for NHS on NICE recommendation
Bayer’s heart failure drug bound for NHS on NICE recommendation is a pharma and life sciences industry update from Pharmaceutical Technology. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Bayer's Kerendia will become available to English patients with chronic heart failure with preserved or mildly reduced ejection fraction.
Source: Pharmaceutical Technology